Skip to content

Effect of Robotic Treatments on Motor Functions in Subacute Stroke Patients

Effect of Robotic Treatments on Motor Functions in Subacute Stroke Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05947773
Enrollment
45
Registered
2023-07-17
Start date
2023-07-09
Completion date
2023-09-01
Last updated
2023-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

robotic, stroke, rehabilitation

Brief summary

We are conducting a three-group comparative study on stroke patients. The treatment is started in a subacute state and completed in the hospital. The essence of robot-assisted treatments is faster recovery and better learning to walk. The group will do a special walking exercise with a robot. The walking group does the same training, only without robotic assistance. The control group will receive physiotherapy treatments financed by the state. Control examination after 3 weeks.

Interventions

OTHERLearning to walk with a robot

The patients completed a 1-hour learning to walk program using a soft exoskeleton. The protocol includes several difficult parts of the walk. (Walking protocol)

The walking protocol was performed without robotic assistance for 1 hour every day for 3 weeks.

OTHERControl group

The control group performed the physiotherapy treatment for 3 weeks.

Sponsors

Somogy Megyei Kaposi Mór Teaching Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
55 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

post stroke 6MWT : 120\> minimum after stroke 3 days be a stroke patient first stroke hemiplegia

Exclusion criteria

multiple strokes, inability to stand and walk, cognitive function disorder does not reach 50 meters with a minimal walking aid Alcohol Sever heart problem sever demeanor alcoholism drug problems Drug

Design outcomes

Primary

MeasureTime frameDescription
Modified Rankin Scale (mRS)3 weeks (0-5 score, high score better)stroke, diagnostic, quality of life

Secondary

MeasureTime frameDescription
Barthel Index for Activities of Daily Living (ADL)3 weeksstroke quality of life
Berg Balance Scale3 weeks (0-30, high score better)balance test
10-m maximal walking speed3 weekshigh speed test
6MWT3 weekswalking test

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026